Latest California Healthline Stories
Two voices from law enforcement disagree on ballot measure to legalize marijuana.
Garen Wintemute, an ER doctor, gun violence researcher and advocate of tighter firearms restrictions, finds opportunity in the wake of mass shootings like the one that struck an Orlando night club last month.
Two state senators and a health foundation executive offer their perspectives.
A researcher and MinuteClinic executive discuss the conclusions in a recent study suggesting that the clinics actually add to outpatient costs.
As baby boomers grow old, demand for long-term care is expected to explode. But it is expensive, and the patchwork system that pays for it now won’t be sustainable for much longer. A debate about new ways to finance it is heating up.
The California Drug Price Relief Act would mandate that the state pay no more for prescription drugs than the U.S. Department of Veterans Affairs. David Gorn sat down with Rand Martin, Sacramento lobbyist for the AIDS Healthcare Foundation, which is sponsoring the ballot measure, and Kathy Fairbanks, campaign consultant for the committee opposing it.
What will Medi-Cal look like 50 years from now? We asked health officials, policy experts and consumer advocates to predict what might happen to California’s program as Medicaid embarks on its second half century.
We asked stakeholders, experts, consumer advocates and legislators how California state and local governments should create and pay for systems to properly dispose of old and unwanted prescription drugs.
Two years before it’s scheduled to kick in, the Affordable Care Act’s “Cadillac tax” on high-end health insurance is generating debate. We asked consumer advocates, employers, insurers and other stakeholders to weigh in.
As Congress convenes hearings examining the issue, we asked legislators, consumer advocates and stakeholders to weigh in on the pros and cons of consolidation in the health insurance industry.